WKN DE: A2PHDZ / ISIN: AU0000043945

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV		Knock-Outs
Historisch			Analysen

Kurse + Charts + Realtime
Kurs + Chart
Chart (groß)
Times + Sales
Chartvergleich
Börsenplätze
Realtime Push
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Aktion
Portfolio
Watchlist

Alteriry Therapeutics Times and Sales (STU)

Zeit	Kurs	Umsatz (Stk)	Umsatz grafisch
21:56:04	0,200
21:46:45	0,200
21:32:55	0,200
21:17:04	0,200
21:03:11	0,200
20:47:52	0,200
20:31:59	0,200
20:17:27	0,200
20:02:24	0,200
19:47:49	0,200
19:32:53	0,200
19:17:48	0,200
19:03:11	0,200
18:47:43	0,200
18:34:02	0,200
18:18:29	0,200
18:03:43	0,200
17:48:19	0,200
17:33:05	0,200
17:19:31	0,200
17:03:57	0,200
16:33:54	0,200
16:18:38	0,200
15:50:44	0,200
15:33:28	0,200
15:30:01	0,200
15:18:44	0,200
15:14:03	0,200
15:02:25	0,200
14:47:34	0,200
14:32:12	0,200
14:17:39	0,200
13:47:40	0,200
13:31:48	0,200
13:17:24	0,200

Kursrückgang	Kursanstieg	keine Kursänderung
(Balkenlänge beschreibt das Umsatzvolumen)

Analysen zu Alteriry Therapeutics Ltd Registered Shs

Weitere Meldungen

23:37		CoreWeave brechen ein: Kreditsorgen ziehen Tech-Werte runter
23:29		Stock Market Today, Oct. 16: Apple Edges Higher on iPhone Duo Preorder Surge
23:28		Here's How Many Shares of AbbVie You'd Need for $5,000 in Yearly Dividends
23:23		Stock Market Today, Oct. 16: Tesla Slips 2% as Roadster Reveal Fades Before Earnings
23:23		Not Alphabet. Not Microsoft. This Is the Cloud Stock I'd Buy With $5,000 Right Now.
23:17		General American Investors CEO Priest Buys Nearly $100k in Preferred Stock. Should Investors Be Paying Attention?
22:47		Inflation Rose to 3.7% in September. Is It Time to Sell the S&P 500?
22:47		Bloom Energy vs. Constellation Energy: Which Energy Stock Is an AI-Driven Buy in 2026?
22:42		Big Tech stocks suffer biggest weekly drop since ‘liberation day’
22:42		Big Tech stocks suffer biggest weekly drop since ‘liberation day’
22:30		If You Invested $100 In Dollar Tree Stock 20 Years Ago, You Would Have This Much Today
22:15		Anthropic In Talks with NYC Comptroller After He Demands an IPO Delay
22:15		Here’s How Much You Would Have Made Owning Entegris Stock In The Last 15 Years
22:05		EchoStar’s stock looks like a stealthy way to ride the SpaceX wave, J.P. Morgan says
22:02		Chip Stocks Endure Longest Losing Streak Since 2006 as CoreWeave Credit Concerns Mount: This Week on Wall Street
22:00		Here's How Much $100 Invested In Johnson Controls Intl 15 Years Ago Would Be Worth Today
21:59		Ericsson: 3 Key Takeaways for Long-Term Investors
21:43		Ukrainian President Zelenskyy speaks at EU summit amid spat with Donald Trump
21:35		Microsoft wants to make AI cheaper. Will investors actually see the savings?
21:30		Lam Research Could Swing $28.6 Billion After Earnings
21:23		Warren Buffett's Berkshire Compounded at 19.7% a Year Between 1965 and 2025, Nearly Double the S&P 500's 10.5% Annual Return. Can Investors Still Apply That Playbook Today?
21:22		QQQ vs. Cheaper Nasdaq-100 ETFs: Why BlackRock And State Street Aren't Winning Investors Yet
21:20		Albertsons: 3 Key Takeaways for Long-Term Investors
21:09		Schroders Capital Warns AI Expectations and Valuations Could ‘Eventually Correct’
21:03		Waymo Puts Toronto on the Map for Its Robotaxis
20:57		Canada’s new foreign investment rules: What critical minerals miners need to know
20:55		Not Nvidia. Not TSMC. This Equipment Maker Is the Real Bottleneck in AI Chip Production.
20:53		Pfizer Just Declared Its 352nd Straight Quarterly Dividend. Is the 6% Yield Safe?
20:45		ExxonMobil’s Refining Profits Are Set to Jump $4.5 Billion. Here’s What XOM Investors Need to Know.
20:38		Independent Bank (INDB) Q3 2026 Earnings Call Transcript
20:38		Forget Zepbound: 3 Newer Drugs That Could Power Eli Lilly's Next Leg Higher
20:37		Could an Anthropic IPO put your 401(k) at risk? The AI safety debate hits a new dimension.
20:31		Jensen Huang's Nvidia Lost $200 Billion in Value After OpenAI's Revenue Run Rate Came Up $18 Billion Below Expectations. Is This AI-Jitters Sell-Off a Buying Opportunity?
20:29		Taiwan Semiconductor Manufacturing Doubles Down on CapEx as Agentic AI Expands, Say Bullish Analysts
20:28		U.S. Budget Deficit Nears $2 Trillion, a Reality Check for Trump’s Cost Cutting
20:28		GameStop’s Collectibles Push, Trading Card Buybacks, eBay Stake Offer Strategic Upside, Analyst Says
20:20		Shopify Price Hikes Signal Pricing Power as JPMorgan Keeps $200 Bullish Target
20:17		Palantir Technologies Stock Is Falling Friday: What's Going On?
20:16		Dutch Bros Has Lost a Third of Its Value in 2026. Is It Time to Buy?
20:10		Perfect Stock Portfolio: October 2026 Edition
20:01		Welcome to the ‘AI burnout trade’ — as investors grow tired of debating tech’s promises
20:00		U.S. Budget Deficit Nears $2 Trillion, a Reality Check for Trump’s Cost Cutting
20:00		From 2009 to 2026 and Beyond, Apple Has Remained 1 of the Most Valuable Companies in the World: Here's the Most Important Takeaway for Investors
19:54		Deal Dispatch: Ithaca Holdings Buys Bumble for $1.3B, The Knot Acquires Zola, Character.ai Bankruptcy
19:53		Travelers (TRV) Q3 2026 Earnings Call Transcript
19:47		Hijab ban at schools in Azerbaijan: What's behind the rare wave of protests?
19:37		SpaceX Will Target Rural America Before Big Cities, Telecom Analyst Predicts
19:36		Why Applied Optoelectronics Stock Plummeted This Week
19:35		At summit, EU leaders pledge support for Ukraine's Zelenskyy
19:32		CoreWeave Stock Crashes 20% This Week, but JPMorgan Says Wall Street Is Overreacting

1 | Weiter

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Weitere Aktien: Cansortium IVERIC bio Plato Income Maximiser Embraer Companhia Paranaense de Energia - COPEL ADR -B- Cert Deposito Arg Repr 3 Sp ADRs -B-

Kontakt - Impressum - Werbung - Barrierefreiheit

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2026 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 81% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	16.10.2026 23:43
Kaufwert:	EUR
	Hinzufügen Speichern

Alteriry Therapeutics Aktie

WKN DE: A2PHDZ / ISIN: AU0000043945

Alteriry Therapeutics Times and Sales (STU)

Analysen zu Alteriry Therapeutics Ltd Registered Shs

Weitere Meldungen